✦ LIBER ✦

Cancer therapy potential of conjugates between a toxin subunit and antibodies (immunotoxins) II — in vitro and in vivo properties of immunotoxins

✍ Scribed by B. Pau; H.E. Blythman; D. Carriere; P. Casellas; F.K. Jansen; P. Poncelet; G. Richer; G.A. Voisin

Publisher: Elsevier Science
Year: 1980
Tongue: English
Weight: 80 KB
Volume: 2
Category: Article
ISSN: 0192-0561
DOI: 10.1016/0192-0561(80)90243-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cancer therapy potential of conjugates b

Cancer therapy potential of conjugates between a toxin subunit and antibodies (immunotoxins) I — preparation of a disulphide conjugate between an antibody and the highly purified A-chain of ricin

✍ F. Paolucci; P. Gros; J.R. Hennequin; B. Pau; S.L. Salhi; H. Vidal 📂 Article 📅 1980 🏛 Elsevier Science 🌐 English ⚖ 80 KB

Evaluation of four CD22 antibodies as ri

Evaluation of four CD22 antibodies as ricin a chain-containing immunotoxins for the in vivo therapy of human B-cell leukemias and lymphomas

✍ Guo-Liang Shen; Jia-Ling Li; Maria-Ana Ghetie; Victor Ghetie; Richard D. May; Ma 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 French ⚖ 668 KB

Ricin A chain-containing immunotoxins (IT-As) specific for the human &ell antigen, CD22, were prepared from 4 monoclonal antibodies (MAbs) or their Fab' fragments: RFB4, HD6, UV22-I and UV22-2. The ITS were tested for their ability to kill cells from the Burkitt lymphoma line, Daudi, the pre-6cell l